» Authors » J Zachary Porterfield

J Zachary Porterfield

Explore the profile of J Zachary Porterfield including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 278
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Anzalone A, Beasley W, Murray K, Hillegass W, Schissel M, Vest M, et al.
J Rural Health . 2024 Jul; 41(1):e12857. PMID: 38953158
Purpose: To investigate the enduring disparities in adverse COVID-19 events between urban and rural communities in the United States, focusing on the effects of SARS-CoV-2 vaccination and therapeutic advances on...
2.
Toman J, Porterfield J, Randall M, Kumar A, Farrior E
JPRAS Open . 2024 Mar; 40:68-76. PMID: 38434944
Background: The discovery of penicillin marked a paradigm shift in medicine with the ability to treat previously life-threatening infections. Increasing antibiotic resistance as well as the risk of adverse reactions...
3.
Horwitz L, Thaweethai T, Brosnahan S, Cicek M, Fitzgerald M, Goldman J, et al.
PLoS One . 2023 Jun; 18(6):e0286297. PMID: 37352211
Importance: SARS-CoV-2 infection can result in ongoing, relapsing, or new symptoms or other health effects after the acute phase of infection; termed post-acute sequelae of SARS-CoV-2 infection (PASC), or long...
4.
Kapalamula G, Gordie K, Khomera M, Porterfield J, Toman J, Vallario J
Audiol Res . 2023 Apr; 13(2):271-284. PMID: 37102774
Methods: A Pre-Survey, followed by an educational intervention, and a Post-Survey were completed by teacher participants. A similar World Health Organization-derived survey was also administered to compare to our locally...
5.
Anderson C, VanHoose J, Burgess D, Burgess D, Schadler A, Porterfield J, et al.
Antimicrob Steward Healthc Epidemiol . 2023 Jan; 2(1):e198. PMID: 36712472
Objective: The objective of this study was to determine antibiotic appropriateness based on Loeb minimum criteria (LMC) in patients with and without altered mental status (AMS). Design: Retrospective, quasi-experimental study...
6.
Anzalone A, Sun J, Vinson A, Beasley W, Hillegass W, Murray K, et al.
PLoS One . 2023 Jan; 18(1):e0279968. PMID: 36603014
Background: While COVID-19 vaccines reduce adverse outcomes, post-vaccination SARS-CoV-2 infection remains problematic. We sought to identify community factors impacting risk for breakthrough infections (BTI) among fully vaccinated persons by rurality....
7.
Fardoos R, Nyquist S, Asowata O, Kazer S, Singh A, Ngoepe A, et al.
Front Immunol . 2022 Nov; 13:912038. PMID: 36330531
Lymphoid tissues are an important HIV reservoir site that persists in the face of antiretroviral therapy and natural immunity. Targeting these reservoirs by harnessing the antiviral activity of local tissue-resident...
8.
Khodaverdi M, Price B, Porterfield J, Bunnell H, Vest M, Anzalone A, et al.
JAMIA Open . 2022 Aug; 5(3):ooac066. PMID: 35911666
Objectives: Although the World Health Organization (WHO) Clinical Progression Scale for COVID-19 is useful in prospective clinical trials, it cannot be effectively used with retrospective Electronic Health Record (EHR) datasets....
9.
Starr N, Porterfield J, Harryman C, Gupta N
Aesthetic Plast Surg . 2022 Jan; 46(5):2398-2403. PMID: 35043249
Background: Both autologous and cadaveric grafts are often used during rhinoplasty to create volume and provide support. Despite discussion in the literature comparing the efficacy, cost-effectiveness, and complication rates between...
10.
Asowata O, Singh A, Ngoepe A, Herbert N, Fardoos R, Reddy K, et al.
JCI Insight . 2021 Oct; 6(22). PMID: 34618690
HIV infection in the human gastrointestinal (GI) tract is thought to be central to HIV progression, but knowledge of this interaction is primarily limited to cohorts within Westernized countries. Here,...